- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 16/18 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans
Patent holdings for IPC class C07K 16/18
Total number of patents in this class: 12335
10-year publication summary
|
947
|
1017
|
966
|
1033
|
942
|
925
|
841
|
837
|
787
|
463
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1127 |
216 |
| Alexion Pharmaceuticals, Inc. | 648 |
193 |
| Genentech, Inc. | 4099 |
166 |
| Ablynx N.V. | 426 |
153 |
| The Regents of the University of California | 20720 |
142 |
| Regeneron Pharmaceuticals, Inc. | 4698 |
129 |
| Amgen Inc. | 4425 |
122 |
| Eli Lilly and Company | 4089 |
108 |
| Chugai Seiyaku Kabushiki Kaisha | 1422 |
106 |
| F. Hoffmann-La Roche AG | 7836 |
104 |
| Prothena Biosciences Limited | 192 |
102 |
| H. Lundbeck A/S | 1231 |
98 |
| Hoffmann-La Roche Inc. | 3783 |
97 |
| AC Immune S.A. | 267 |
88 |
| Sanofi | 4293 |
86 |
| The Trustees of the University of Pennsylvania | 4414 |
78 |
| Novartis AG | 10263 |
75 |
| Nordic Bioscience A/S | 141 |
61 |
| Bristol-myers Squibb Company | 4729 |
60 |
| The Johns Hopkins University | 5875 |
60 |
| Other owners | 10091 |